NovaBay Pharmaceuticals to Hold First Quarter 2020 Conference Call on May 7, 2020
April 27 2020 - 4:15PM
Business Wire
NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a medical
device company based in the San Francisco Bay Area, announces that
it will report first quarter 2020 financial results after market
close on Thursday, May 7, 2020 and will hold an investment
community conference call that day.
DATE:
Thursday, May 7
TIME:
4:30 p.m. ET / 1:30 p.m. PT
DIAL IN:
800-608-8202 from within the U.S.
702-495-1913 from outside the U.S.
Enter conference identification number
7080709
The live call also will be available at
http://novabay.com/investors/events. A replay of the call will be
available beginning two hours after its completion through 11:59
p.m. Eastern time May 28, 2020, by dialing 855-859-2056 from within
the U.S. or 404-537-3406 from outside the U.S. and entering the
conference identification number 7080709. The call will also be
archived at http://novabay.com/investors/events.
About NovaBay Pharmaceuticals, Inc.: Going Beyond
Antibiotics®
NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company
focusing on commercializing and developing its non-antibiotic
anti-infective products to address the unmet therapeutic needs of
the global, topical anti-infective market with its two distinct
product categories: the NEUTROX® family of products and the
AGANOCIDE® compounds. The Neutrox family of products includes
AVENOVA® for the eye care market, CELLERX® for the aesthetic
dermatology market and NEUTROPHASE® for the wound care market. The
Aganocide compounds, still under development, have target
applications in the dermatology and urology markets.
Socialize and Stay informed on
NovaBay’s progress: Like us on Facebook Follow us
on Twitter Connect with NovaBay on LinkedIn Join us
on Google+ Visit NovaBay’s Website
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200427005823/en/
Avenova Purchasing
Information For NovaBay Avenova purchasing information:
Please call 800-890-0329 or email sales@avenova.com.
www.Avenova.com NovaBay Contact
Justin Hall, President and Chief Executive Officer 510-899-8800
jhall@novabay.com Investor
Contact LHA Investor Relations Jody Cain 310-691-7100
jcain@lhai.com
NovaBay Pharmaceuticals (AMEX:NBY)
Historical Stock Chart
From Aug 2024 to Sep 2024
NovaBay Pharmaceuticals (AMEX:NBY)
Historical Stock Chart
From Sep 2023 to Sep 2024